Author

Boopathi Subramaniyan

Cedars-Sinai Medical CenterORCID 0000-0003-0243-3777Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Assay:metabolomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Bipul R. AcharyaiD· 1 shared Candice Bui-LinhiD· 1 shared Chorlada PaiboonrungruangiD· 1 shared Corazon Gutierrez· 1 shared Dan TheodorescuiD· 1 shared Fangyuan Qu· 1 shared Francis J. SpitziD· 1 shared Hai‐Ning WangiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Bipul R. AcharyaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintAug 26, 2025

Loss of the Y chromosome drives cancer metabolic reprogramming

Boopathi Subramaniyan, Bipul R. Acharya, Prince Anand…·Dan Theodorescu

The paper shows that loss of the Y chromosome in bladder cancer drives metabolic reprogramming through DDR2, enhancing glycolysis and tumor aggressiveness.

2 citations

humanmetabolomics

𝕏 PostBluesky

Cancer BiologybioRxivPreprintAug 18, 2025

Pyrimethamine inhibits mutant NRF2 as a molecular glue

Zhaohui Xiong, Chorlada Paiboonrungruang, Hai‐Ning Wang…·Xiaoxin Luke Chen

This study shows that pyrimethamine inhibits mutant NRF2 by acting as a molecular glue to restore KEAP1 binding, enhancing therapy sensitivity in ESCC.

DOI 10.1101/2025.08.18.670902

humanexperimental assay

𝕏 PostBluesky